What is PharmaCann?
PharmaCann, established in 2014 and headquartered in Chicago, IL, is dedicated to enhancing quality of life through the discovery, production, and responsible dispensing of cannabis-related products. The company aims to be a leader in the science-based understanding of cannabis's impact on healthcare and wellness industries. Its vision is rooted in leveraging scientific research to unlock the full potential of cannabis for therapeutic and wellness applications, positioning itself at the forefront of a rapidly evolving market.
How much funding has PharmaCann raised?
PharmaCann has raised a total of $194.9M across 3 funding rounds:
Corporate Investment
$110.4M
Debt
$39.5M
Other Financing Round
$45M
Corporate Investment (2021): $110.4M with participation from The Cronos Group
Debt (2022): $39.5M, investors not publicly disclosed
Other Financing Round (2022): $45M supported by Innovative Industrial Properties
Key Investors in PharmaCann
Innovative Industrial Properties
Innovative Industrial Properties is a real estate investment trust specializing in acquiring, owning, and managing industrial properties leased to licensed cannabis operators. Their investment in PharmaCann highlights a focus on supporting the infrastructure and operational needs of the regulated cannabis industry.
The Cronos Group
The Cronos Group is a global cannabinoid company with international production and distribution capabilities. Their corporate investment in PharmaCann suggests a strategic alignment in expanding global reach and product development within the cannabis sector.
What's next for PharmaCann?
With a recent major strategic investment and substantial overall capital, PharmaCann is poised for significant advancement. The company's focus on science-based understanding and responsible dispensing suggests a strategic expansion into new markets or the enhancement of existing product lines and research initiatives. This enterprise-level funding will likely support scaling operations, further research and development into cannabis's medicinal properties, and potentially broader market penetration, solidifying its role in the burgeoning cannabis wellness industry.
See full PharmaCann company page
